This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1993 Sep 11;342(8872):631-2.

doi: 10.1016/0140-6736(93)91755-b.

Competing in drug safety

R Edwards¹

Affiliations

PMID: 8103142
DOI: 10.1016/0140-6736(93)91755-b

Comment

Competing in drug safety

R Edwards. Lancet. 1993.

. 1993 Sep 11;342(8872):631-2.

doi: 10.1016/0140-6736(93)91755-b.

Author

R Edwards¹

Affiliation

¹ WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden.

PMID: 8103142
DOI: 10.1016/0140-6736(93)91755-b

No abstract available

PubMed Disclaimer

Comment in

Prescriber profile and postmarketing surveillance.
Kimbel KH. Kimbel KH. Lancet. 1993 Nov 6;342(8880):1178-9. Lancet. 1993. PMID: 7901504 No abstract available.

Comment on

Prescriber profile and post-marketing surveillance.
Inman W, Pearce G. Inman W, et al. Lancet. 1993 Sep 11;342(8872):658-61. doi: 10.1016/0140-6736(93)91763-c. Lancet. 1993. PMID: 8103150

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information